Increased Non‐Relapse Mortality in Older People With Allogeneic Hematopoietic Stem Cell Transplantation Using Fludarabine and Myeloablative Dose of Busulfan‐Based Regimen

Documenti analoghi

• Myeloablative Busulfan, Fludarabine and Melphalan Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Childhood Myeloid Malignancy
  di: Mayank Dhamija, et al.
  Pubblicazione: (2026)
• Impact of Conditioning Intensity on Clinical Outcomes of Second Allogeneic Hematopoietic Cell Transplantation for Relapse After First Transplantation
  di: Kazuki Yoshimura, et al.
  Pubblicazione: (2025)
• Adverse Impact of Pre‐Transplant Liver Dysfunction in Allogeneic Hematopoietic Cell Transplantation
  di: Yukiko Misaki, et al.
  Pubblicazione: (2025)
• Platelet Recovery and Its Impact on Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation: A Japanese Nationwide Retrospective Study
  di: Naoki Kurita, et al.
  Pubblicazione: (2025)
• Long‐Term Survival After Allogeneic Hematopoietic Stem Cell Transplantation for BCR::ABL1‐Negative Atypical Chronic Myeloid Leukemia: A Nationwide Retrospective Study by Adult CML/MPN and MDS Working Groups of the Japanese Society for Transplantation and Cellular Therapy
  di: Hidehiro Itonaga, et al.
  Pubblicazione: (2025)